Monday, October 1, 2012

New FDA hand-held scanner sheds light on counterfeits Agency might sell its patented device to other regulators September 27, 2012 | By Eric Palmer Read more: New FDA hand-held scanner sheds light on counterfeits - FiercePharma Manufacturing http://www.fiercepharmamanufacturing.com/story/new-fda-hand-held-scanner-sheds-light-counterfeits/2012-09-27?utm_source=rss&utm_medium=rss#ixzz284qKoVCa Subscribe: http://www.fiercepharmamanufacturing.com/signup?sourceform=Viral-Tynt-FiercePharma Manufacturing-FiercePharma Manufacturing


Agency might sell its patented device to other regulators


Read more: New FDA hand-held scanner sheds light on counterfeits - FiercePharma Manufacturing http://www.fiercepharmamanufacturing.com/story/new-fda-hand-held-scanner-sheds-light-counterfeits/2012-09-27?utm_source=rss&utm_medium=rss#ixzz284qSCJAx
Subscribe: http://www.fiercepharmamanufacturing.com/signup?sourceform=Viral-Tynt-FiercePharma Manufacturing-FiercePharma Manufacturing

Drug giants fined $11bn for criminal wrongdoing; Fines are not enough to reform drug industry, warn lawyers


The Independent has an article entitled Drug Giants Fined $11bn for Criminal Wrongdoing, written by Jeremy Laurance and published September 20, 2012.  To read this article click here.

Washington State Board of Pharmacy: Ther-Rx Corp Letter


The Washington State Board of Pharmacy had on its September 27, 2012 agenda to discuss:

3.10 Correspondence. The board may discuss any correspondence received or distributed. Information/Action.
a) Ther-Rx Corp. letter re: Compounding of Hydroxyprogesterone Caproate

Once the minutes to the meeting are posted, I will update you on what position the Washington State Board of Pharmacy has taken.

Another FDA lawsuit over Exclusivity


FDA Law blog is reporting  that there is another  Orphan Drug Battle in that Depomed has Sued the FDA Over GRALISE Orphan Drug Exclusivity.  The complaint and post can be read here.